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The C/EBPβ LIP isoform rescues loss 
of C/EBPβ function in the mouse
Valérie Bégay1,2, Christian Baumeier1,3, Karin Zimmermann1, Arnd Heuser4 & Achim Leutz  1,5
The transcription factor C/EBPβ regulates hematopoiesis, bone, liver, fat, and skin homeostasis, and 
female reproduction. C/EBPβ protein expression from its single transcript occurs by alternative in-frame 
translation initiation at consecutive start sites to generate three isoforms, two long (LAP*, LAP) and 
one truncated (LIP), with the same C-terminal bZip dimerization domain. The long C/EBPβ isoforms are 
considered gene activators, whereas the LIP isoform reportedly acts as a dominant-negative repressor. 
Here, we tested the putative repressor functions of the C/EBPβ LIP isoform in mice by comparing 
monoallelic WT or LIP knockin mice with Cebpb knockout mice, in combination with monoallelic 
Cebpa mice. The C/EBPβ LIP isoform was sufficient to function in coordination with C/EBPα in murine 
development, adipose tissue and sebocyte differentiation, and female fertility. Thus, the C/EBPβ LIP 
isoform likely has more physiological functions than its currently known role as a dominant-negative 
inhibitor, which are more complex than anticipated.
The CCAAT enhancer binding protein family of transcription factors (C/EBP) regulates several cellular processes 
including cell growth, proliferation, differentiation, apoptosis, senescence, and tumorigenesis. C/EBPβ, a member 
of the C/EBP family, controls cell fate in fat, skin, bone, mammary tubulogenesis, female reproduction, and the 
innate immune system1–3. C/EBPβ is encoded by a single exon gene that is transcribed into a single mRNA and 
translated by alternative initiation from consecutive in-frame start codons into three protein isoforms, LAP*, 
LAP, and LIP4. The truncated isoform, C/EBPβ LIP, lacks the N-terminal trans-activating and central regulatory 
regions contained in the long LAP*, LAP isoforms, but may still form dimers via the common C-terminal bZip 
domain (Fig. 1a). Regulation of the C/EBPβ LAP/LIP ratio plays an important role in liver regeneration, acute 
phase response, bone homeostasis, metabolic adjustment, monocyte differentiation, tumorigenesis, and mam-
mary gland development3,5–10.
The truncated C/EBPβ LIP isoform is widely considered a trans-dominant repressor and a competitive inhib-
itor that fails to activate transcription, because it lacks an activation domain, and “neutralizes” or “blocks” other 
C/EBP, ATF, and Jun family members3,11,12. Alternative translation of C/EBPβ LIP is required to abrogate C/
EBPα-mediated suppression of S-phase entry in liver regeneration9,13. C/EBPβ LIP also induces osteoclastogene-
sis by inhibiting MafB, which acts as an inhibitor of osteoclast differentiation8. Further, C/EBPβ LIP is involved in 
the regulation of cyclin D1 target genes, which are typically repressed by C/EBPβ LAP14.
Most of our knowledge on the gene regulatory mechanisms of LIP is derived from tissue culture experiments 
and transient ectopic expression approaches. However, examination of isoform-specific functions in live ani-
mals remains essential for understanding the physiology of C/EBPβ-regulated processes. In mice, deregulated 
expression of the C/EBPβ LIP isoform causes many diseases related to deregulated cell proliferation, including 
tumorigenesis5,15. Considering the established view that C/EBPβ LIP is a genetic repressor, we recently observed 
that embryonic fibroblasts (MEF) generated from CebpbL/L knockin mice (L/L), expressing only the LIP iso-
form from its endogenous genetic locus, fail to differentiate into adipocytes in tissue culture (data not shown). 
Although these data corroborate the conclusions drawn from ectopic expression of C/EBPβ LIP in murine pread-
ipocytic 3T3L1 cells16, L/L animals developed white and brown fat. The discrepancy between both systems may 
be ascribed to the requirement of mitotic clonal expansion of the preadipocytes in vitro that is controlled by C/
EBPβ LAP*/LAP and inhibited by C/EBPβ LIP17, although controversial views do exist18. Thus, the physiological 
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roles of C/EBPβ isoforms are difficult to discern from cell culture experiments. We therefore employed a genetic 
approach to explore the functions of C/EBPβ LIP in live animals.
In this study, we compared the phenotype of monoallelic Cebpb−/LIP (−/L) mice with that of mice lacking 
one or both Cebpb alleles (Cebpb+/−, Cebpb−/−). Our results showed that a single Cebpb LIP allele rescued fat 
cell differentiation, prevented hair loss, and partially restored postnatal growth and female fertility. Thus, the 
Figure 1. Fat metabolism in Cebpb mutant mice. (a) Schematic representation of C/EBPβ expression. 
Environmental conditions regulate the activity of the translation initiation machinery. A cis-regulatory uORF 
in the single C/EBPβ transcript adjusts initiation of translation at conserved in-frame start sites to generate 
3 C/EBPβ isoforms, as indicated. WT mice produce 3 C/EBPβ isoforms, LAP*, LAP, and LIP. The CebpbLIP 
knockin mice produce the truncated C/EBPβ LIP isoform only, which lacks trans-activating and regulatory C/
EBPβ regions. (b) Body weight analysis of Cebpb mutant mice. Body weights were recorded weekly between 
weeks 1 and 4, and then monthly until sacrifice. Statistical differences were assessed by two-way ANOVA within 
genotype (P < 0.0001) followed by Bonferroni post-hoc test with each time point. (c) Gonadal fat pad weight. 
(d) Histomorphometric analysis of white fat sections of Cebpb male mutant mice at 4 and 12 months. Scale 
bar, 20 μm. (e) Quantification of the fat cell area as shown in (d). (f) Fat content and (g) lean body mass. In all 
panels, bars indicate mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 by Student’s t-test. In all panels except 
where indicated otherwise, mice were 20 weeks of age, n = 6–17 mice per genotype.
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physiological functions of truncated C/EBPβ LIP are far more complex than those of an ordinary genetic on/off 
switch and trans-dominant repressor.
Results
Tissue culture transactivation assay results suggest that the truncated C/EBPβ isoform LIP exhibits dominant 
interfering function towards full-length C/EBP proteins. We therefore expected the biological impact of bial-
lelic C/EBPβ LIP expression from its endogenous locus in mice to be more severe than the C/EBPβ knockout 
phenotype. However, L/L mice did not show hair loss or reduced body weight, two apparent phenotypes of 
Cebpb-deficient mice (Supplementary Fig. 1a,b), at any age. We therefore performed rescue experiments by using 
mice that expressed only one allele either of WT (Cebpb+/−, β+/−, used as control), C/EBPβ LIP (Cebpb−/L, −/L), 
or no C/EBPβ (Cebpb−/−, β−/−), to elucidate the role of the C/EBPβ LIP isoform in live animals.
Cebpb−/− mice exhibit lipodystrophy whereas Cebpb−/LIP mice do not. C/EBPβ, together with C/
EBPδ, induces the expression of C/EBPα and PPARγ at the onset of fat cell differentiation, and subsequently 
regulates the expression of adipokines, including leptin19–25. Chow-fed age-matched β+/−, −/L, and β−/− mice 
were generated and monitored over 20 weeks. Western blot analysis revealed that C/EBPβ LAP*, LAP, and LIP 
isoforms were expressed in white (WAT) and brown (BAT) adipose tissues of β+/− mice. Only the C/EBPβ 
LIP isoform was found in the WAT and BAT of −/L mice, and none of the isoforms were present in β−/− 
mice (Supplementary Fig. 2a BAT). The body weight of β−/− and −/L mice was significantly reduced compared 
to that of β+/− control mice, which were indistinguishable from WT controls (Fig. 1b). Similarly, the body 
and tibia lengths of β−/− and −/L mice were significantly reduced compared to those of the β+/− controls 
(Supplementary Fig. 2c,d). Cebpb-deficient mice also showed decreased weight of gonadal fat pads and reduced 
adipocyte cell size compared to β+/− animals (Fig. 1c–e). These phenotypes advanced with age (comparing 2–4 
and 12 months; Fig. 1d,e). However, no significant decrease in the weight of gonadal fat pads was found in −/L 
mice (Fig. 1c), and adipocyte size was indistinguishable at 2–4 months and slightly increased at 12 months com-
pared to β+/− controls (Fig. 1d,e). Similarly, liver, pancreas, and BAT weight of −/L mice were indistinguishable 
from those of control mice (Supplementary Fig. 2b). Reduced body weight was accompanied by a reduction of 
total fat mass in β−/− mice but not in −/L mice, as determined by body composition analysis (BCA; Fig. 1f). 
Furthermore, β−/− mice displayed a significant increase in lean body mass (Fig. 1g), suggesting that the decrease 
in body weight could be associated with increased energy expenditure, activity, reduced energy intake, or com-
binations thereof. Further, food intake was increased in β−/− mice (Fig. 2a), consistent with the finding that 
plasma leptin and leptin transcripts in adipocytes were decreased (Fig. 2b). Unlike in β−/− mice, food uptake 
and leptin plasma levels in −/L mice were similar to those in the controls (Fig. 2a,b), and a slight increase in leptin 
mRNA was observed in −/L mice (Fig. 2b).
The decrease in fat cell size in β−/− mice compared with control mice suggests that adipocyte differentiation 
or function was likely compromised in β−/− animals but not in −/L mutants. Real time PCR analysis showed that 
lipoprotein lipase (Lpl) and the immature adipocyte marker fatty-acid binding protein 4 (aP2) expressions were 
slightly increased in −/L mice, while expression of the mature adipocyte marker phosphoenolpyruvate carboxyki-
nase (Pepck) remained unchanged, compared to control littermates, indicating that adipogenic differentiation fully 
occurred (Fig. 2c). Finally, plasma triglycerides and free fatty acid (FFA) content decreased by at least 50% in β−/− 
mice but not in −/L mice (Fig. 2d,e, respectively), likely due to the decreased adipose tissue mass in β−/− mice.
The data obtained from β−/− mice are in accordance with previous reports25,26. Our data confirm the occur-
rence of lipodystrophy after removal of all C/EBPβ isoforms. Surprisingly, we now show genetic rescue by a single 
copy of the truncated C/EBPβ LIP isoform in fat development and homeostasis.
A single copy of the truncated C/EBPβ LIP isoform rescues alopecia and female fertility of 
Cebpb knockout mice. Cebpb-deficient mice showed a progressive hair-fall phenotype and eventually devel-
oped hair loss (alopecia) at an advanced age. This phenotype was not observed at any age in −/L mice (Fig. 3a 
and Supplementary Fig. 1a). Mutations in genes associated with sebaceous gland function lead to loss of hair after 
several hair cycles27. Sebocytes are specialized fat cells of the skin, located in the hair shaft, which produce oily 
sebum to waterproof and protect hair from drying. C/EBPβ is expressed in sebocytes of the sebaceous glands, 
where it plays a role in differentiation and lipid metabolism28. Germline deletion revealed a role of Cebpb in the 
early epidermal keratinocyte differentiation29 and conditional deletion of Cebpb in the skin induced a mild phe-
notype28,30,31. We analyzed the skin of age-matched −/L, β−/−, and β+/− mice to determine whether the rescue 
of white fat cell differentiation extends to sebocytes. Cebpb-deficient mice lost their hair (Fig. 3a) and displayed 
increased epidermal thickness (Fig. 3b). This phenotype was accompanied by reduced number of differentiated 
sebocytes at 2–4 months of age (Supplementary Fig. 2e), and became more severe with age (Fig. 3c,d). The hair 
loss phenotype was completely rescued in −/L mice, even at advanced age (Fig. 3a–d). Analysis of the epidermis 
indicated normalization of epidermal thickness and sebocyte numbers per hair follicle in −/L mice (Fig. 3b,d). 
Thus, the C/EBPβ LIP isoform is sufficient to sustain both keratinocyte and sebocyte differentiation.
Another severe phenotype observed in female β−/− mice is sterility due to an impairment of granulosa cell 
differentiation32. We observed that L/L female mice were sterile. However, −/L female mice became pregnant but 
rarely gave birth (Fig. 3e and Supplementary Table 1). Analysis of the uterus of −/L females mice at stage E18.5 
showed that several embryos were formed, of which most became necrotic (Fig. 3e). This suggests that the C/
EBPβ LIP isoform is sufficient to support fertility to some extent, and indicates dose-dependent functions of LIP.
A single copy of the truncated C/EBPβ LIP isoform partially rescues the immune phenotype of 
Cebpb−/− mice. C/EBPβ is involved in innate and adaptive immune functions, acute phase response and 
regulation of cytokine production7,33–35. IL6 and TNFα were found elevated in the serum of β−/− mice and 
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Figure 2. Adipocyte differentiation and lipid homeostasis in Cebpb mutant mice. (a) Food intake per mouse, 
normalized to body weight as determined over 4 consecutive days. (b) Plasma level of leptin and real-time PCR 
analysis of leptin in gonadal fat pad. (c) Real-time PCR analysis of the adipocyte differentiation markers Lpl 
(pre-adipocytes), aP2 (immature adipocytes), and Pepck (mature adipocytes). (d) Plasma levels of triglycerides 
and free fatty acids (FFA). In all panels, data are presented as mean ± SEM. *P < 0.05, **P < 0.01 by Student’s t-
test. Mice were 5-month-old (b–d) or 8-week-old (a), n = 4–7 per genotype.
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splenomegaly was observed at 16 weeks of age33,34. Serum levels of IL6 and TNFα are also increased in our young 
adult β−/− mice (2 month-old), whereas IL6 and TNFα levels remain normal in L/L mice (Supplementary 
Fig. 3a). At 12 months of age, IL6 and TNFα were significantly increased in both, β−/− and in L/L mice, although 
Figure 3. The C/EBPβ LIP isoform rescues keratinocyte and sebocyte differentiation and female fertility. (a) 
Representative photograph of the fur of Cebpb male mutant mice. (b) H&E staining of dorsal skin showing an 
increase in epidermal (e) thickness (black line) in β−/− but not in −/L mice. (d) Dermis. Scale bar, 10 μm. 
Quantification of epidermal thickness is shown on the right, n = 4–7 per group. (c) Trichrome staining of dorsal 
skin showing hair follicle (hf) lacking sebocytes (arrowhead) in  β−/− mice but not in −/L mice. Scale bar, 
20 μm. (d) Quantification of the number of hair follicle with sebocytes (%) in Cebpb mutant mice, n = 8–9 per 
genotype. (e) Representative photographs of the uterus of + /L and −/L females at stage E18.5. Note that in −/L 
uterus most of the embryos (e) are necrotic (arrowhead) except one, which reached full development. Placenta 
(p), uterus (u), fat (f), and ovary (o). Quantification of the number of newborn per litter (right panel), n = 5–17 
per genotype (also see Supplementary Table 1). In all panels, data are presented as mean ± SEM. **P < 0.01, 
***P < 0.001, ****P < 0.0001 by Student’s t-test and the mice were 12 months of age in (a–d).
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variability was observed between animals (Supplementary Fig. 3a). At 5 months of age, β−/− mice showed 
increased white blood cells (WBC) counts (Supplementary Fig. 3b) and splenomegaly (Supplementary Fig. 3c). 
The data obtained from β−/− mice are in accordance with previous reports33,34. In contrast, one allele of LIP 
restored WBC (Supplementary Fig. 3b) and normalized or even slightly diminished spleen size (Supplementary 
Fig. 3c). Moreover, no splenomegaly was observed in +/L or L/L mice at 2 months of age (Supplementary Fig. 1c). 
Our data suggest that the C/EBPβ LIP isoform to some extent restored immunity that might contribute to the 
extended lifespan of −/L mice in comparison to β−/− mice (Supplementary Fig. 3d).
The C/EBPβ LIP isoform functions in conjunction with C/EBPα in fat and skin homeostasis and 
postnatal survival. Of the 6 mammalian C/EBP family members (α, β, δ, ε, γ, and CHOP), C/EBPα and C/
EBPβ are essential transcription factors that regulate development and physiology19,21,30,36. Previous studies have 
shown redundancies/specificities of C/EBP family members. For instance, Cebpb expressed from the Cebpa locus 
supports postnatal survival and could functionally replace C/EBPα in the liver but not in adipose tissue37. Compound 
loss of Cebpa and Cebpb in mice (Cebpa−/−; Cebpb−/−, or α−/−; β−/−), caused early embryonic lethality, whereas a 
single copy of either Cebpa in the absence of Cebpb or Cebpb in the absence of Cebpa rescued development, suggest-
ing redundant functions of both C/EBPs during embryogenesis36. At the molecular level, C/EBPβ and C/EBPα may 
form heterodimers that bind to DNA. We therefore determined whether LIP could rescue essential functions of C/
EBPβ in conjunction with monoallelic Cebpa. We generated and compared mice that expressed a single Cebpa allele 
in the absence of Cebpb (Cebpa+/−; Cebpb−/−) or in the presence of LIP (Cebpa+/−; Cebpb−/L or Cebpa+/−; CebpbL/L). 
The few young adult Cebpa+/−; Cebpb−/− (or α+/−; β−/−) mice obtained showed a dramatic skin phenotype 
(Fig. 4a), reduced body weight (Fig. 4b), reduced fat pad weight (Fig. 4c) with fat pad lipoatrophy (Fig. 4a), increased 
liver weight (Supplementary Fig. 4a), and splenomegaly (Supplementary Fig. 4b), and had to be euthanized within 
2–3 months because of severe cachexia, infection, and skin lesions. In contrast, mice with a single copy of Cebpa and 
a single copy of Cebpb LIP (Cebpa+/−; Cebpb−/L or α+/−; −/L) showed almost complete rescue of the hair phenotype 
(Fig. 4a). Interestingly, Cebpa+/−; Cebpb−/L mice showed a substantial decrease in body weight (Fig. 4b), while liver, 
BAT and spleen weight remained unaltered in comparison to compound heterozygote Cebpa+/−; Cebpb+/− mice 
(Supplementary Fig. 4a,b). Fat pad morphology showed adipocytes of various sizes that resembled the adipocyte 
morphology of control littermates (Fig. 4a), but the overall amount of fat pad was reduced (Fig. 4c). Importantly, a 
single copy of Cebpa in Cebpb−/− mice only marginally supported birth and postnatal survival (mendelian ratio of 
around 1.2% instead of 12.5% at birth; Supplementary Table 2 and36). Interestingly, mice expressing one Cebpa allele 
in CebpbL/L were born at only slightly reduced mendelian ratio (9.09% instead of 12.5%, Supplementary Table 2), dis-
played no macroscopic alterations, and survived at least 6–12 months (data not shown). Mice expressing one Cebpa 
allele in Cebpb−/L were born at a lower mendelian ratio (5.43% instead of 12.5%, Supplementary Table 2), suggesting 
dose-dependent effects of the C/EBPβ LIP isoform in postnatal survival. Taken together, our results indicated that 
a single Cebpb LIP isoform allele was sufficient to rescue survival and hair loss. Thus, the LIP isoform likely acts in 
conjunction with monoallelic C/EBPα to rescue several postnatal functions in mice.
Discussion
The truncated LIP isoform of C/EBPβ lacks a transactivation domain, and has been classified as a repressor of 
transcription and an antagonist of the long C/EBP isoforms.
In this study, we compared the phenotype of monoallelic Cebpb−/LIP mice with that of mice lacking one or 
both Cebpb alleles. Our results showed that several defects caused by the absence of the Cebpb gene could be 
compensated by the truncated C/EBPβ LIP isoform. The functions of C/EBPβ LIP observed in live animals are 
difficult to be explained by mechanisms of trans-dominant interference. Thus, the classification of C/EBPβ LIP as 
a dominantly interfering transcription factor likely depends on temporal and cellular context and requires to be 
revisited in light of the physiological data presented in this report.
Correct temporal expression of the C/EBP family members C/EBPβ, C/EBPδ, and C/EBPα, is crucial for the 
execution of the adipogenic differentiation program19–21,23. Reduced fat pad mass was observed in Cebpb−/−; 
Cebpd−/− mice25,26, and inhibition of DNA binding of all C/EBP members in fat tissue led to a biphasic lipod-
ystrophy syndrome with loss of WAT at birth38. These results were largely in agreement with the expected role 
of C/EBPs in murine adipogenesis39. CCAAT/enhancer binding protein homologous protein (CHOP) has been 
identified as a negative regulator of C/EBP function and CHOP-deficient mice show increased body weight and 
adiposity compared to littermate controls39,40. Further, in tissue culture, CHOP could inhibit C/EBPα and C/
EBPβ function during fat cell differentiation41,42. Therefore −/L and L/L mice could be expected to show similar 
fat phenotypes. However, our data show that the C/EBPβ LIP isoform is sufficient to sustain fat and skin devel-
opment and homeostasis along with C/EBPα. According to trans-dominant functions of C/EBPβ LIP deduced 
from ectopic expression experiments, −/L mice would have been expected to show a more dramatic phenotype 
on fat tissue, skin and even acceleration of early postnatal death due to hypoglycemia as in Cebpa−/− mice30,43. 
Moreover, a more severe immune phenotype, aggravating effects of highly deficient myelopoiesis was expected, as 
seen in compound C/EBPβ and C/EBPε knockouts44. However, with the stipulation that animals were kept under 
specific-pathogen-conditions, −/L mice did not show gross immune defects and survived to at least 20 months, 
much longer than Cebpb−/− mice. Finally, Cebpa+/−; Cebpb−/L mice clearly showed rescue of pathology and lethal 
phenotypes, as compared to Cebpa+/−; Cebpb−/− mice, such as restoration of the skin phenotype. It is tempting to 
speculate that complementation of C/EBPβ deficiency by LIP isoform occurs through partially restored immune 
functions, however, C/EBPβ LIP failed to rescue many innate and adaptive immune defects5,7,45. Altogether, our 
data suggest residual essential functions of the truncated C/EBPβ LIP isoform. Surprisingly, expression of C/EBP 
target genes in adipose tissues (WAT and BAT) of −/L mice were similar to those of Cebpb−/ΔuORF mice, express-
ing only LAP*/LAP (Supplementary Fig. 5).
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C/EBPβ binds directly to the leptin promoter and activates leptin expression23,25, however, our data suggest 
that the C/EBPβ LIP isoform is sufficient to fulfill leptin gene regulation, since both leptin transcript expres-
sion in WAT and leptin levels in the blood in −/L mice remained normal. Architectural and/or functional fea-
tures of the conserved region 7 (CR7), DNA binding bZip domain, and residues in the C-terminus common to 
all C/EBPβ isoforms (Fig. 1a) are thus sufficient for functional complementation. Phosphorylation by MAPK/
ERK1,2 of C/EBPβ at threonine 188 and in the leucine zipper are important for DNA binding and activation of 
the adipogenic program and these sites also reside in C/EBPβ LIP isoform20,46,47. Furthermore, both, β−/− and 
L/L female mice failed to become pregnant (Supplementary Table 1 and32), however, CebpbΔuORF/ΔuORF female 
mice expressing only LAP*/LAP could reproduce with the normal mendelian ratio9. Fertility has been linked to 
MAPK/ERK1,2-dependent phosphorylation of C/EBPβ to activate critical genes in the oocyte48. Interestingly, we 
observed that −/L female mice could become pregnant but rarely carried to full term. These data suggest that a 
single LIP allele (in Cebpb−/L) could also support fecundity but not late pregnancy. The fact that −/L but not L/L 
female mice could become pregnant emphasizes the importance of LIP isoform dosage in vivo and potentially its 
balanced co-function with C/EBPα. The dosage of the C/EBPβ LIP isoform expression thus also emerges as an 
important quantitative aspect to be addressed, shifting the focus to adjustment of isoform ratios by the C/EBPβ 
uORF. How the level of LIP expression influence target gene expression still remains to be determined. Taking 
advantage of the mono versus bi-allelic +/L and L/L mice no antagonal effects between one or two copies of LIP 
Figure 4. The C/EBPβ LIP isoform functions in tandem with C/EBPα in fat and skin homeostasis. (a) 
Representative photographs of the fur (left panels) of Cebpa+/−; Cebpb+/−, Cebpa+/−; Cebpb−/−, and Cebpa+/−; 
Cebpb−/L mice. H&E staining of white fat sections of Cebpb mutant mice (right panels). Scale bar, 50 μm. (b) 
Body weight and (c) fat pad weight of Cebpa+/−; Cebpb+/−, Cebpa+/−; Cebpb−/−, and Cebpa+/−; Cebpb−/L mice at 
death. In all panels, data are presented as mean ± SEM. **P < 0.01, ***P < 0.001 by Student’s t-test. Mice were 
8–12 weeks of age, n = 3–7 per genotype.
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were found in preliminary studies on potential C/EBPβ target gene expression in B cells (Supplementary Fig. 6), 
however, such analysis will have to be extended to the whole animal physiology. Furthermore, the MAPK/ERK1,2 
sites that are retained in C/EBPβ LIP could further be studied in the future to help explain the rescue of Cebpb−/L 
female fertility and other phenotypes.
Taken together, our and published data warrant reevaluation of the functions of the truncated isoforms of 
both, C/EBPβ (this publication) and C/EBPα49. Future work will have to address how C/EBPβ LIP or the cor-
responding truncated C/EBPα p30 isoform might compensate for loss of the entire genes. Of particular future 
attention are the genomic distribution of C/EBP isoforms, their interactome and genomic co-localization with 
co-activating or repressing machinery, in addition to large scale structural alterations of chromatin.
In summary, data presented here strongly suggest that the C/EBPβ LIP isoform that lacks the transactivation 
domain is more complex than a trans-dominant inhibitor and rescues essential functions of native C/EBPβ by 
mechanisms that remain to be explored. A full understanding of the complexity of C/EBPα and C/EBPβ regu-
lation at the physiological-mechanistic level clearly remains challenging but nevertheless will be important to 
eventually develop novel therapeutic strategies for the successful treatment of C/EBP-related disorders in home-
ostasis and tumorigenesis.
Material and Methods
Animals. The Cebpb and Cebpa knockout strains and CebpbLIP knockin mice have been previously 
described8,32,43. Mouse strains were maintained on a 129 × C57BL/6N genetic background, because CebpbL/L 
and Cebpb−/− mice died in the C57BL/6N genetic background. For more details about mouse strains, see 
Supplementary Methods in SI. Data presented were obtained from female mice, unless indicated otherwise. Mice 
were fed ad libitum with standard diet and water on a 12-h light-dark cycle. Animals were housed in a path-
ogen-free facility at the MDC, Berlin. All procedures and animal experiments were conducted in compliance 
with protocols approved by the institutional Animal Care and Use Committee Landesamt für Gesundheit und 
Soziales Berlin (LAGeSo). Mice were sacrificed by cervical dislocation. All efforts were made to minimize animal 
suffering.
Histology. Fat pads were collected, fixed overnight in 4% paraformaldehyde, embedded in paraffin, sectioned 
at 4 μm, and stained with hematoxylin & eosin according to the standard protocol. Images were acquired using a 
Zeiss AxioCam Hr camera. Five randomly chosen microscope fields were photographed at 200X magnification 
for each animal, and analyzed using the Zeiss AxioVision Software program (version 4.2).
Biochemical assay. Blood was collected by heart puncture of non-fasted mice after killing by cervical dislo-
cation. Serum leptin was measured using the mouse leptin RIA kit (Millipore). Serum triglycerides (LabAssayTM 
Triglyceride, Wako-chemicals) and free fatty acid (NEFA-HR(2), Wako-chemicals) were determined using col-
orimetric assays.
Body composition. Body composition was measured in awaken 20-week-old female mice by using Time 
Domain Nuclear Magnetic Resonance (Minispec LF90 II - Bruker BioSpin). Testing was conducted in randomly 
fed mice that were fasted for 3 h before measurement.
Food intake. Food intake was measured in female mice at 8 weeks. Mice were caged individually and 
adapted for at least 48 h before measuring food intake. Food consumption was determined for 4 consecutive days, 
expressed as g/day, and normalized to the body weight of the mice.
RNA isolation and real-time quantitative PCR analysis. Total RNA was isolated using TriPure isola-
tion reagent (Roche). Total RNA (2 μg) was treated with DNAse (Invitrogen) and reverse transcribed at 42 °C by 
using Superscript II (Invitrogen). Real-time quantitative PCR was performed on a LightCycler type II (Roche) 
using the SYBR Green Master Mix (Roche). Expression of 36B4 or Tbp was used to normalize individual RNA 
expression levels. The data were expressed as relative RNA expression levels, calculated using the comparative CT 
method. The control expression level was set at 1. Sequences of primers pairs used can be provided upon request.
Cell culture and immunoblotting. Mouse embryonic fibroblasts and 3T3-L1 murine preadipocytes were 
cultured in DMEM supplemented with 10% FBS (Invitrogen). Tissues and cells were lysed with 8 M urea and pro-
teins were analyzed by SDS/PAGE/protein blotting using rabbit C/EBPβ antibody (C19, Santa Cruz) and mouse 
anti-β-tubulin (2-28-33, Sigma), horseradish peroxidase-conjugated secondary antibodies, and chemilumines-
cence detection (Amersham Biosciences).
Statistical analysis. All data are expressed as mean ± SEM. Data were first tested for normal distri-
bution. Statistically significant differences between groups were determined using the unpaired two-tailed 
Mann-Whitney’s test unless indicated otherwise (Prism 5, GraphPad Software). P-value < 0.05 was considered to 
be statistically significant.
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